US group n = 31 | KDD group n = 31 | Control group n = 20 | Between group p value | |
---|---|---|---|---|
Pre treatment VAS score | 7.19 ± 1.60**a | 6.51 ± 1.72**a | 6.70 ± 1.49**a | 0.249* |
Post treatment VAS score | 4.25 ± 2.26a | 4.25 ± 4.20a | 3.15 ± 1.81a | 0.379* |
1 month post treatment VAS score | 3.96 ± 2.68a | 3.48 ± 2.04a | 3.45 ± 1.63a | 0.621* |
3 month post treatment VAS score | 3.41 ± 2.74a | 3.64 ± 2.21a | 2.95 ± 1.84a | 0.588* |
Within group p | < 0.001** | < 0.001** | < 0.001** | |
Pre treatment M.Oswestry | 48.48 ± 18.20b | 50.19 ± 13.35b | 40.90 ± 17.16b | 0.127* |
Post treatment M.Oswestry | 36.19 ± 17.00a,b | 34.80 ± 12.03a,b | 23.30 ± 13.84a.b | 0.006* |
1 month post treatment M.Oswestry | 25.22 ± 16.92a | 28.19 ± 17.36a | 19.70 ± 17.26a | 0.232* |
3 month post treatment M.Oswestry | 26.45 ± 21.90a | 28.51 ± 16.95a | 18.60 ± 10.54a | 0.145* |
Within group p | < 0.001** | < 0.001** | < 0.001** |